Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients

Free Radical Biology and Medicine

Volumn 35, Issue 2, 2003, Pages 140-148

  Hageman, Geja J ^a   Larik, Ingrid ^a   Pennings, Herman Jan ^a,b   Haenen, Guido R M M ^a   Wouters, Emiel F M ^a   Bast, Aalt ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Astmacenter Hornerheide   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Free radicals; Inflammatory cytokines; Oxidative stress; PARP; Physiopathology

Indexed keywords

ANTIOXIDANT; DNA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); REACTIVE OXYGEN METABOLITE; TROLOX C; URIC ACID;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; FEMALE; HUMAN; HYPOTHESIS; IMMUNOFLUORESCENCE; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

RICKETTSIA SP. PAR;

EID: 0037485683     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00237-5     Document Type: Article

References (39)

1. Repine J.E., Bast A., Lankhorst I. the Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:1997;341-357.
2. MacNee W., Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol. Med. 7:2001;55-62.
3. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1 what have learned from the deficient mouse model? Mutat. Res. 460:2001;1-15.
4. Das S.K., Berger N.A. Alterations in deoxynucleoside triphosphate metabolism in DNA-damaged cells identification and consequences of poly(ADP-ribose) polymerase-dependent and -independent processes . Biochem. Biophys. Res. Commun. 137:1986;1153-1158.
5. Szabó C., Dawson V.L. Pole of poly(ADP-ribose) synthase in inflammation and ischemia/reperfusion. Trends Pharmacol. Sci. 19:1998;287-298.
6. Grant R.S., Passey R., Matanovic G., Smythe G., Kapoor V. Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages a self-protective mechanism? Arch. Biochem. Biophys. 372:1999;1-7.
7. Szabó C., Saunders C., O'Connor M., Salzman A.L. Peroxynitrite causes energy depletion and increases permeability via activation of poly(ADP-ribose) synthetase in pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 16:1997;105-109.
8. Liaudet L., Pacher P., Mabley J.G., Virag L., Soriano F., Hasko G., Szabó C. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am. J. Respir. Crit. Care Med. 165:2002;372-377.
9. Pouw E.M., Koerts-de Lange E., Gosker H.R., Van der Vusse G.J., Wouters E.F., Schols A.M. Muscle metabolic status in patients with severe COPD with and without long-term prednisolone. Eur. Resp. J. 16:2000;247-252.
10. Gosker H.R., Wouters E.F., Van der Vusse G.J., Schols A.M. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure underlying mechanisms and therapy perspectives . Am. J. Clin. Nutr. 71:2000;1033-1047.
11. + as a biochemical measure of niacin status in humans. Methods Enzymol. 280:1997;221-230.
12. Van den Berg R., Haenen G.R.M.M., Van den Berg H., Bast A. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem. 66:1999;511-517.
13. Hageman G.J., Stierum R.H., van Herwijnen M.H.M., Van der Veer M.S.E., Kleinjans J.C.S. Nicotinic acid supplementation effects on niacin status, cytogenetic damage, and poly(ADP-ribosylation) in lymphocytes of smokers . Nutr. Cancer. 32:1998;113-120.
14. Williams G.T., Lau K.M., Coote J.M., Johnstone A.P. NAD metabolism and mitogen stimulation of human lymphocytes. Exp. Cell Res. 160:1985;419-426.
15. Payne C.M., Crowley C., Washo-Stultz D., Briehl M., Bernstein H., Bernstein C., Beard S., Holubec H., Warneke J. The stress-response proteins poly(ADP-ribose) polymerase and NF-κB protect against bile salt-induced apoptosis. Cell Death Diff. 5:1998;623-636.
16. Bouma M.G., Stad R.K., Van den Wildenberg F.A., Buurman W.A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:1994;4159-4168.
17. Dentener M.A., Bazil V., Von Asmuth E.J., Ceska M., Buurman W.A. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6, and IL-8 release by human monocytes and alveolar macrophages. J. Immunol. 150:1993;2885-2891.
18. Bouma M.G., Laan M.P., Dentener M.A., Buurman W.A. Analysis of soluble adhesion molecules. Johnstone A.P., Turner M.W. Immunochemistry 2: a practical approach. 1997;181-186 Oxford University Press, Oxford.
19. Szabó C., Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischemia/reperfusion. Trends Pharmacol. Sci. 19:1998;287-298.
20. Jijon H.B., Churchill T., Malfair D., Wessler A., Jewell L.D., Parsons H.G., Madsen K.L. Inhibition of poly(ADP-ribose) polymerase attenuated inflammation in a model of chronic colitis. Am. J. Physiol. 279:2000;G641-G651.
21. Soriano F.G., Virág L., Jagtap P., Szabó E., Mabley J.G., Marton A., Hoyt D.G., Murthy K.G.K., Salzman A.L., Southan G.J., Szabó C. Diabetic endothelial dysfunction the role of poly(ADP-ribose) polymerase activation . Nature Med. 7:2001;108-113.
22. Stierum R.H., Van Herwijnen M.H.M., Hageman G.J., Kleinjans J.C.S. Increased poly(ADP-ribose) polymerase activity during repair of (+)-anti-benzo[a]pyrene diolepoxide-induced DNA damage in human peripheral blood lymphocytes in vitro. Carcinogenesis. 15:1994;745-751.
23. Chiarugi A. Poly(ADP-ribose) polymerase killer or conspirator? The "suicide hypothesis" revisited . Trends Pharm. Sci. 23:2002;122-129.
24. Fu C.S., Swenseid M.E., Jacob R.A., McKee R.W. Biochemical markers for assessment of niacin status in young men levels of erythrocyte niacin coenzymes and plasma tryptophan . J. Nutr. 119:1989;1949-1955.
25. + concentration during hyperoxida and niacin deficiency in the Fischer-344 rat. Free Radic. Biol. Med. 20:1996;865-871.
26. Hageman G.J., Stierum R.H. Niacin, poly(ADP-ribose) polymerase-1, and genomic stability. Mutat. Res. 475:2001;45-46.
27. Schols A.M., Soeters P.B., Mostert R., Saris W.H., Wouters E.F. Energy balance in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1991;1248-1252.
28. Rice-Evans C., Miller N. Measurement of the antioxidant status of dietary constituents, low-density lipoproteins, and plasma. Leukotrienes Essential Fatty Acids. 57:1997;499-505.
29. Rahman I., Swarska E., Macnee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax. 52:1997;565-568.
30. Rahman I., Swarska E., Henry M., Stolk J., MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive disease? Thorax. 55:2000;189-193.
31. Pesci A., Balbi B., Majori M., Cacciani G., Bertacco S., Alciato P., Donner C.F. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 12:1998;380-386.
32. Bresser P., Out T.A., Van Alphen L., Jansen H.M., Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Am. J. Respir. Crit. Care Med. 162:2000;947-952.
33. Bhowmik A., Seemungal T.A., Sapsford R.J., Wedzicha J.A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 55:2000;114-120.
34. Aaron S.D., Angel J.B., Lunau M., Wright K., Fex C., Le Saux N., Dales R.E. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163:2001;349-355.
35. Schols A.M., Buurman W.A., Staal-van den Brekel A.J., Dentener M.A., Wouters E.F. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 51:1996;819-824.
36. Wedzicka J.A., Seemungal T.A.R., MacCallum P.K., Paul E.A., Donaldson G.C., Bhownik A., Jeffries D.J., Meade T.W. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb. Haemost. 84:2000;210-215.
37. Noguera A., Busquets X., Sauleda J., Villaverde J.M., MacNee W., Agusti A.G.N. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158:1998;1664-1668.
38. Kameoka M., Ota K., Tetsuka T., Tanaka Y., Itaya A., Okamoto T., Yoshihara K. Evidence for regulation of NF-κB by poly(ADP-ribose) polymerase. Biochem. J. 346:2000;641-664.
39. Hassa P.O., Covic M., Hasan S., Imhof R., Hottiger M.O. The enzymatic and DNA-binding activity of PARP-1 are not required for NF-κB coactivator function. J. Biol. Chem. 276:2001;45588-45597.